US Patent

US8147852 — Modified azole compounds as antifungal and antibacterial agents

Method of Use · Assigned to Barrier Therapeutics Inc · Expires 2028-03-30 · 2y remaining

Vulnerability score 80/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects the use of modified azole compounds as antifungal and/or antibacterial agents.

USPTO Abstract

The present invention relates to the compounds of formula (I), their preparation and use as antifungal and/or antibacterial agents. where the values for R 1 , R 2 , R 3 , R 4 , R 5 and A are as defined herein.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1426`	—

Patent Metadata

Patent number: US8147852
Jurisdiction: US
Classification: Method of Use
Expires: 2028-03-30
Drug substance claim: No
Drug product claim: No
Assignee: Barrier Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.